NewLink Genetics Corp (NLNK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Key Findings: - Unique new report provides deep financial benchmarks for (NewLink Genetics Corp (NLNK:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. - Benchmarking study for (NewLink Genetics Corp ) includes growth forecast for its primary industry to the year 2024.
The purpose of this report is to provide vital corporate-specific benchmarks, comparing the Subject Company to its top competitors (on a company-by-company basis) and to the averages within its primary industry for all key metrics.
This is a unique report containing high-value data. The report begins with a superb overview of the primary industry of the Subject Company, including historical industry revenues, revenue forecasts and CAGR. Then the report moves into industry averages and metrics, then into data specific to the Subject Company, with comparative data for the Subject Company’s top competitors. This report will save countless hours of research and analytical work for the end user.
Core Benefits to Customer: 1) Comprehensive benchmarks for the Subject Company: a. Benchmarked against the leading firms in its primary industry b. Benchmarked against the average for publicly-held companies (U.S.) in its industry. c. This includes financial results, ratios, vital statistics and metrics in one package, including historical and current metrics and averages for 6 years within its primary industry. 2) A snapshot overview of the company’s primary industry, including current and historic revenues and employment, along with a long term forecast for industry growth, with CAGR (compound annual growth rate), employee population and much more. 3) Detailed rankings of the Subject Company against top companies within the industry (U.S.-based firms) for key items including: a. Approximate market capitalization b. Employees c. Revenues d. Net income e. 3-Year revenue growth (%) f. 3-Year income growth (%) g. Return on assets (%) h. Return on equity (%) i. Return on invested capital (%) 4) Leading companies-profiles of the Subject Company as well as profiles of top competitors within the industry
This report is part of the Plunkett’s Corporate Benchmarks series, published by the Plunkett Analytics unit of Plunkett Research, Ltd. Plunkett Research has unique capabilities for creating corporate and industry information, due to the industry and company research that we have been conducting for more than 20 years. Our access to hundreds of industry tables from our own databases, along with our databases of public and private company information, industry trends analysis and other resources, have been utilized in preparing this report. Similar reports are available for all significant, U.S. publicly-held firms.
Designed to benefit: - Analysis and Financial Modeling -Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants
Companies Profiled: - Johnson & Johnson - Procter & Gamble Co - Pfizer Inc - Dow Chemical Company (The) - Merck & Co Inc - Gilead Sciences Inc - AbbVie Inc - DuPont (E I du Pont de Nemours & Co) - ExxonMobil Chemical - Amgen Inc
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Zero Liquid Discharge (ZLD) Systems Market Report The zero liquid discharge (ZLD) systems market is expected to reach USD 10.22 billion by 2026, growing at a CAGR of 8.57% during the forecast period 2021-2026 The following factors...
The global process analytical instrumentation market is expected to witness a CAGR of 7.56% over the forecast period (2021-2026). In the market analyzed, the recent COVID-19 outbreak resulted in high demand. During the COVID-19 outbreak, the need for accelerated research has grown substantially, and the public expects exceptional progress...
247 pages •
By Future Market Insight Global & Consulting Pvt Ltd
• Aug 2021
A recent market study published on the glass reactors market includes global industry analysis for 2016-2020 and opportunity assessment for 2021-2031, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters of the glass reactors market,...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the desiccants market are Porocel, The Dow Chemical, INEOS, Fuji Silysia Chemical, and Hengye Molecular Sieve. The global desiccants market is expected to grow from $0.13 billion in 2020 to $0.14 billion in 2021 at a compound annual growth rate (CAGR) of 7.7%. The growth is mainly due to the companies resuming their...
The thermal pallet covers market was valued at US$ 4,599.65 million in 2021 and is projected to reach US$ 10,469.73 million by 2028; it is expected to grow at a CAGR of 12.5% from 2021 to 2028. Thermal pallet covers safeguard temperature-sensitive goods from the effects of harsh weather and decrease the risk of excursions.The heat transmission...
Cushing’s Syndrome - Opportunity Assessment and Forecast to 2030 Summary Cushing’s Syndrome is a disorder caused by the body’s exposure to an excess of the hormone cortisol.Cortisol affects all tissues and organs in the body, and collectively these effects are known as CS. This disorder can...
The market for ultra-pure water is expected to record a CAGR of over 5%, globally, during the forecast period. Major factors driving the market studied are the growing demand from the semiconductor industry and increasing application in the pharmaceutical industry. On the flip side, the high consumption of water for purification is expected...
The market for dust control systems and suppression chemicals is valued at USD 12,350 million in 2020 and is expected to grow at a CAGR of more than 4% during the forecast period. Restrictions by governments in various countries due to the spread of COVID-19 have placed difficulties on mining companies operating in affected countries....
The global pharmaceutical contract development and manufacturing market is projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% during the forecast period. Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.